XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating Expenses:        
Research and development $ 11,669 $ 8,268 $ 25,596 $ 23,884
General and administrative 3,076 4,357 9,939 10,367
Total operating expenses 14,745 12,625 35,535 34,251
Loss from operations (14,745) (12,625) (35,535) (34,251)
Other income (expense):        
Grant income 7,684 5,947 18,035 18,236
Other income (expense), net 314 55 (129) (182)
Interest expense (2) (2) (18) (18)
Total other income, net 7,996 6,000 17,888 18,036
Net Loss (6,749) (6,625) (17,647) (16,215)
Unrealized gain (loss) on foreign currency translation   (1) 3 (3)
Total comprehensive loss $ (6,749) $ (6,626) $ (17,644) $ (16,218)
Net loss per share, basic (in dollars per share) $ (0.22) $ (0.29) $ (0.59) $ (0.71)
Net loss per share, diluted (in dollars per share) $ (0.22) $ (0.29) $ (0.59) $ (0.71)
Weighted-average common shares outstanding, basic (in shares) 30,365,506 23,024,026 29,696,296 22,684,309
Weighted-average common shares outstanding, diluted (in shares) 30,365,506 23,024,026 29,696,296 22,684,309